Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 32Observational 2Expanded_access 2

Sponsor

Cancer Type

Gastrointestinal 21Head & Neck 2Genitourinary 1

Conditions

Thyroid Neoplasms 2

Interventions

Surveys and Questionnaires 40Blood Specimen Collection 30Radiotherapy 20Immunohistochemistry 13Gene Expression Profiling 12Radiotherapy, Intensity-Modulated 11Cisplatin 11Surgical Procedures, Operative 10Biopsy 10Drug Therapy 9Cetuximab 9Ultrasonography 8Thyroidectomy 8Observation 8Transurethral Resection of Prostate 7Nivolumab 7Interviews as Topic 7pembrolizumab 6Therapeutics 6Radiation 6Polymerase Chain Reaction 6Immunotherapy 6Biopsy, Fine-Needle 6Positron Emission Tomography Computed Tomography 5Microarray Analysis 5Liquid Biopsy 5Iodine-131 5Docetaxel 5Chemoradiotherapy 5Tissue Banks 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × lenvatinib × Head & Neck × Clear all
NCT07419932 2026-02-19

NeoLATC

Fujian Medical University

Recruiting
120 enrolled
Head & Neck

Thyroid Neoplasms

NCT02430714 2020-01-09

Post-marketing Surveillance of Lenvatinib Mesylate (Lenvima Capsule) in Patients With Unresectable Thyroid Cancer (Study LEN01T)

Eisai Inc.

Completed
629 enrolled
Head & Neck

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡